Yüklüyor......
Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis
Osteoporosis, an aging-associated bone metabolic disease, is affecting millions of people worldwide. The deregulated process of osteoblastic differentiation has been linked with the progression of osteoporosis. Trelagliptin is a long-acting inhibitor of DPP-4 used for the management of type 2 diabet...
Kaydedildi:
| Yayımlandı: | Bioengineered |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8291811/ https://ncbi.nlm.nih.gov/pubmed/33734011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2021.1900633 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|